KPI-121 1% Versus Prednisolone for the Treatment of Inflammation Following Cataract Surgery in Children
Public ClinicalTrials.gov record NCT03596723. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety and Efficacy of KPI-121 1% Ophthalmic Suspension Versus Prednisolone Acetate Ophthalmic Suspension 1% for the Treatment of Inflammation Following Cataract Surgery in Children 0 to 3 Years of Age
Study identification
- NCT ID
- NCT03596723
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Kala Pharmaceuticals, Inc.
- Industry
- Enrollment
- 2 participants
Conditions and interventions
Conditions
Interventions
- KPI-121 1% Drug
- Prednisolone acetate Drug
Drug
Eligibility (public fields only)
- Age range
- Up to 3 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2, 2018
- Primary completion
- Sep 27, 2018
- Completion
- Oct 17, 2018
- Last update posted
- Oct 18, 2020
2018
United States locations
- U.S. sites
- 4
- U.S. states
- 4
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Byers Eye Institute at Stanford University | Palo Alto | California | 94303 | — |
| Children's Eye Care, PC | Detroit | Michigan | 48201 | — |
| Pediatric Ophthalmology of Erie, Inc. | Erie | Pennsylvania | 16501 | — |
| Houston Eye Associates | The Woodlands | Texas | 77380 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03596723, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 18, 2020 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03596723 live on ClinicalTrials.gov.